Get the latest Science News and Discoveries

Insilico completes first-in-human dosing in phase I clinical study of AI-driven NLRP3 inhibitor ISM8969, achieving first clinical milestone in collaboration with Hgtia - EurekAlert!

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Related news:

University of Michigan implants first-in-human Paradromics wireless brain-computer interface, designed to restore communication - EurekAlert!

Researchers receive funding to launch USC’s first clinical study of psilocybin for mental health - EurekAlert!

IU collaboration to use AI in identifying possible drug targets for Alzheimer’s patients - EurekAlert!